Mackenzie Financial’s Apellis Pharmaceuticals APLS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.28M | Buy |
74,165
+32,632
| +79% | +$565K | ﹤0.01% | 952 |
|
|
2025
Q1 | $908K | Buy |
41,533
+5,175
| +14% | +$113K | ﹤0.01% | 1008 |
|
|
2024
Q4 | $1.16M | Sell |
36,358
-9,127
| -20% | -$291K | ﹤0.01% | 908 |
|
|
2024
Q3 | $1.31M | Buy |
45,485
+37,546
| +473% | +$1.08M | ﹤0.01% | 810 |
|
|
2024
Q2 | $305K | Sell |
7,939
-23,082
| -74% | -$885K | ﹤0.01% | 1162 |
|
|
2024
Q1 | $1.82M | Sell |
31,021
-10,464
| -25% | -$615K | ﹤0.01% | 755 |
|
|
2023
Q4 | $2.48M | Buy |
+41,485
| New | +$2.48M | ﹤0.01% | 688 |
|
|
2023
Q3 | – | Sell |
-10,007
| Closed | -$893K | – | 1471 |
|
|
2023
Q2 | $893K | Sell |
10,007
-7,655
| -43% | -$683K | ﹤0.01% | 883 |
|
|
2023
Q1 | $1.16M | Buy |
17,662
+7,360
| +71% | +$485K | ﹤0.01% | 831 |
|
|
2022
Q4 | $533K | Sell |
10,302
-35,849
| -78% | -$1.85M | ﹤0.01% | 907 |
|
|
2022
Q3 | $3.15M | Buy |
46,151
+31,355
| +212% | +$2.14M | 0.01% | 602 |
|
|
2022
Q2 | $669K | Buy |
14,796
+10,749
| +266% | +$486K | ﹤0.01% | 909 |
|
|
2022
Q1 | $206K | Buy |
+4,047
| New | +$206K | ﹤0.01% | 1289 |
|